Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin vs Ozurdex for Persistent Diabetic Macular Oedema
NCT01298076Phase 2Completed
- Sponsor
- University of Sydney
- Start
- Oct 2010
- Primary completion
- Sep 2014
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab, dexamethasone in diabetic macular edema (DME), sponsored by University of Sydney. Started Oct 2010; status: completed.
02
Drugs
bevacizumabdexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01298076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01298076.